Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs. The company was incorporated in 2005 and is based in Vancouver, Canada.
Research context
Solarvest BioEnergy Inc appears in PyInvesting’s TSX Venture Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Solarvest BioEnergy Inc is currently in a long term uptrend where the price is trading 14.8% above its 200 day moving average.
From a valuation standpoint, the stock is 5283.1% more expensive than other stocks from the Industrials sector with a price to sales ratio of 1717.0.
Solarvest BioEnergy Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has dropped by 261.2% to $-2M since the same quarter in the previous year.
Finally, its free cash flow grew by 17.9% to $-207K since the same quarter in the previous year.
Based on the above factors, Solarvest BioEnergy Inc gets an overall score of 2/5.